In summary, our study has demonstrated that the serum levels of IL-2RG, hsa-miR-7-5p, and hsa-miR-26b-5p hold promise as non-invasive prognostic biomarkers for CRC patients. Here, IL2RG is linked to colorectal carcinoma.